Loading
KB
Keryx Biopharmaceuticals Inc Stock: price and insider trades · United States
Keryx Biopharmaceuticals Inc: what insiders have been doing
Keryx Biopharmaceuticals Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Keryx Biopharmaceuticals Inc has published a filing in the past twelve months. The most recent one dates from 13 December 2018.
Our records for Keryx Biopharmaceuticals Inc go back to 2016, with no purchases and 88 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
138
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€952,201
88 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Net income-US$145.7M
Last declaration on 13 December 2018
Declarations138 total
35,582,335 shares@ US$4.63100.0% of flowCommon StockSEC:0001567619-18-007897:0
10,469 shares@ US$3.2234.0% of flowCommon StockSEC:0000899243-18-030876:0
4,000,000 sharesCommon StockSEC:0001567619-18-007897:1
65,374,013 sharesCommon StockSEC:0001567619-18-007897:2
20,000 sharesCommon StockSEC:0000899243-18-030886:0
27,333 sharesCommon StockSEC:0000899243-18-030884:0
162,956 sharesCommon StockSEC:0000899243-18-030890:0
120,000 sharesCommon StockSEC:0000899243-18-030889:0
30,000 sharesCommon StockSEC:0000899243-18-030894:0
186,666 sharesCommon StockSEC:0000899243-18-030877:0
100,646 sharesCommon StockSEC:0000899243-18-030876:1
60,000 sharesCommon StockSEC:0000899243-18-030888:0
10,000 sharesCommon StockSEC:0000899243-18-030892:0
148,279 sharesCommon StockSEC:0000899243-18-030881:0
1,155 shares@ US$2.773.6% of flowCommon StockSEC:0001114220-18-000109:0
1,156 shares@ US$2.773.8% of flowCommon StockSEC:0001114220-18-000110:0
1,253 shares@ US$3.074.5% of flowCommon StockSEC:0001114220-18-000100:0
1,254 shares@ US$3.074.3% of flowCommon StockSEC:0001114220-18-000099:0
2,040 shares@ US$3.296.7% of flowCommon StockSEC:0001114220-18-000096:0
1,185 shares@ US$3.044.1% of flowCommon StockSEC:0001114220-18-000094:0
1,186 shares@ US$3.044.2% of flowCommon StockSEC:0001114220-18-000093:0
1,282 shares@ US$3.864.6% of flowCommon StockSEC:0001114220-18-000086:0
2,354 shares@ US$3.868.2% of flowCommon StockSEC:0001114220-18-000085:0
2,021 shares@ US$4.498.9% of flowCommon StockSEC:0001114220-18-000082:0
10,000 shares0Common StockSEC:0001114220-18-000074:0
25 of 138 declarations
About Keryx Biopharmaceuticals Inc
Keryx Biopharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for renal diseases. It is listed on NASDAQ under the ticker KERX.
